featured
Safety and Efficacy of the Novel Incretin Co-Agonist Cotadutide in Patients With Biopsy-Proven Noncirrhotic MASH With Fibrosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Gastroenterology and Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and Efficacy of Novel Incretin Co-agonist Cotadutide in Biopsy-proven Noncirrhotic MASH With Fibrosis
Clin. Gastroenterol. Hepatol. 2024 Sep 01;22(9)1847-1857.e11, SS Shankar, SJ Daniels, D Robertson, J Sarv, J Sánchez, D Carter, L Jermutus, B Challis, AJ SanyalFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.